Literature DB >> 15165694

So what if tangles precede plaques?

J L Price1, J C Morris.   

Abstract

Mesh:

Year:  2004        PMID: 15165694     DOI: 10.1016/j.neurobiolaging.2003.12.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


× No keyword cloud information.
  12 in total

1.  β-Secretase-1 elevation in aged monkey and Alzheimer's disease human cerebral cortex occurs around the vasculature in partnership with multisystem axon terminal pathogenesis and β-amyloid accumulation.

Authors:  Yan Cai; Kun Xiong; Xue-Mei Zhang; Huaibin Cai; Xue-Gang Luo; Jia-Chun Feng; Richard W Clough; Robert G Struble; Peter R Patrylo; Yaping Chu; Jeffrey H Kordower; Xiao-Xin Yan
Journal:  Eur J Neurosci       Date:  2010-08-18       Impact factor: 3.386

2.  What does it take to stay healthy past 100?: Commentary on "No disease in the brain of a 115-year-old woman".

Authors:  Joseph L Price
Journal:  Neurobiol Aging       Date:  2008-06-04       Impact factor: 4.673

3.  Cerebrospinal fluid profiles and prospective course and outcome in patients with amnestic mild cognitive impairment.

Authors:  Ozioma C Okonkwo; Michelle M Mielke; H Randall Griffith; Abhay R Moghekar; Richard J O'Brien; Leslie M Shaw; John Q Trojanowski; Marilyn S Albert
Journal:  Arch Neurol       Date:  2011-01

4.  Cerebrospinal fluid abnormalities and rate of decline in everyday function across the dementia spectrum: normal aging, mild cognitive impairment, and Alzheimer disease.

Authors:  Ozioma C Okonkwo; Michael L Alosco; H Randall Griffith; Michelle M Mielke; Leslie M Shaw; John Q Trojanowski; Geoffrey Tremont
Journal:  Arch Neurol       Date:  2010-06

Review 5.  Origins of Alzheimer's disease: reconciling cerebrospinal fluid biomarker and neuropathology data regarding the temporal sequence of amyloid-beta and tau involvement.

Authors:  Erik S Musiek; David M Holtzman
Journal:  Curr Opin Neurol       Date:  2012-12       Impact factor: 5.710

Review 6.  Current concepts in therapeutic strategies targeting cognitive decline and disease modification in Alzheimer's disease.

Authors:  J Steven Jacobsen; Peter Reinhart; Menelas N Pangalos
Journal:  NeuroRx       Date:  2005-10

Review 7.  Models of β-amyloid induced Tau-pathology: the long and "folded" road to understand the mechanism.

Authors:  Ilie-Cosmin Stancu; Bruno Vasconcelos; Dick Terwel; Ilse Dewachter
Journal:  Mol Neurodegener       Date:  2014-11-18       Impact factor: 14.195

8.  Prediction of Alzheimer's disease pathophysiology based on cortical thickness patterns.

Authors:  Jihye Hwang; Chan Mi Kim; Seun Jeon; Jong Min Lee; Yun Jeong Hong; Jee Hoon Roh; Jae-Hong Lee; Jae-Young Koh; Duk L Na
Journal:  Alzheimers Dement (Amst)       Date:  2015-12-28

9.  Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques.

Authors:  Virginia Garcia-Marin; Lidia Blazquez-Llorca; José-Rodrigo Rodriguez; Susana Boluda; Gerard Muntane; Isidro Ferrer; Javier Defelipe
Journal:  Front Neuroanat       Date:  2009-11-20       Impact factor: 3.856

10.  Longitudinal β-Amyloid Deposition and Hippocampal Volume in Preclinical Alzheimer Disease and Suspected Non-Alzheimer Disease Pathophysiology.

Authors:  Brian A Gordon; Tyler Blazey; Yi Su; Anne M Fagan; David M Holtzman; John C Morris; Tammie L S Benzinger
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.